Statistics about Health, Pharma & Medtech in Japan
Statistics
- Takeda Pharmaceutical Company Limited net cash 2020-2024
- Takeda Pharmaceutical Company Limited total equity 2020-2024
- Shionogi & Co., Ltd. revenue 2020-2024
- Shionogi & Co., Ltd. liabilities 2020-2024
- Shionogi & Co., Ltd. net income 2020-2024
- Shionogi & Co., Ltd. gross profit 2020-2024
- Shionogi & Co., Ltd. net cash 2020-2024
- Shionogi & Co., Ltd. operating profit 2020-2024
- Shionogi & Co., Ltd. total equity 2020-2024
- Shionogi & Co., Ltd. total assets 2020-2024
- Sumitomo Pharma Co., Ltd. net income 2020-2024
- Sumitomo Pharma Co., Ltd. net cash 2020-2024
- Sumitomo Pharma Co., Ltd. revenue 2020-2024
- Sumitomo Pharma Co., Ltd. liabilities 2020-2024
- Sumitomo Pharma Co., Ltd. gross profit 2020-2024
- Sumitomo Pharma Co., Ltd. total assets 2020-2024
- Sumitomo Pharma Co., Ltd. operating profit 2020-2024
- Sumitomo Pharma Co., Ltd. total equity 2020-2024
- Sawai Group Holdings Co., Ltd. net income 2021-2024
- Sawai Group Holdings Co., Ltd. liabilities 2021-2024
- Sawai Group Holdings Co., Ltd. gross profit 2021-2024
- Sawai Group Holdings Co., Ltd. revenue 2021-2024
- Sawai Group Holdings Co., Ltd. operating profit 2021-2024
- Sawai Group Holdings Co., Ltd. total assets 2021-2024
- Sawai Group Holdings Co., Ltd. total equity 2021-2024
- Sawai Group Holdings Co., Ltd. net cash 2021-2024
- Santen Pharmaceutical Co., Ltd. liabilities 2020-2024
- Santen Pharmaceutical Co., Ltd. net income 2020-2024
- Santen Pharmaceutical Co., Ltd. operating profit 2020-2024
- Santen Pharmaceutical Co., Ltd. gross profit 2020-2024
- Santen Pharmaceutical Co., Ltd. revenue 2020-2024
- Santen Pharmaceutical Co., Ltd. total assets 2020-2024
- Santen Pharmaceutical Co., Ltd. total equity 2020-2024
- Shin Nippon Biomedical Laboratories, Ltd. net income 2020-2024
- Shin Nippon Biomedical Laboratories, Ltd. revenue 2020-2024
- Shin Nippon Biomedical Laboratories, Ltd. liabilities 2020-2024
- Shin Nippon Biomedical Laboratories, Ltd. gross profit 2020-2024
- Shin Nippon Biomedical Laboratories, Ltd. operating profit 2020-2024
- Shin Nippon Biomedical Laboratories, Ltd. total assets 2020-2024
- Shin Nippon Biomedical Laboratories, Ltd. net cash 2020-2024
- Shin Nippon Biomedical Laboratories, Ltd. total equity 2020-2024
- Ono Pharmaceutical Co., Ltd. liabilities 2020-2024
- Ono Pharmaceutical Co., Ltd. net cash 2020-2024
- Ono Pharmaceutical Co., Ltd. revenue 2020-2024
- Ono Pharmaceutical Co., Ltd. gross profit 2020-2024
- Ono Pharmaceutical Co., Ltd. operating profit 2020-2024
- Ono Pharmaceutical Co., Ltd. total equity 2020-2024
- Nippon Shinyaku Co., Ltd. net income 2020-2024
- Nippon Shinyaku Co., Ltd. gross profit 2020-2024
- Nippon Shinyaku Co., Ltd. liabilities 2020-2024
- Nippon Shinyaku Co., Ltd. revenue 2020-2024
- Nippon Shinyaku Co., Ltd. total assets 2020-2024
- Nippon Shinyaku Co., Ltd. operating profit 2020-2024
- Nippon Shinyaku Co., Ltd. net cash 2020-2024
- Nippon Shinyaku Co., Ltd. total equity 2020-2024
- Nippon Chemiphar Co., Ltd. net income 2020-2024
- Nippon Chemiphar Co., Ltd. liabilities 2020-2024
- Nippon Chemiphar Co., Ltd. revenue 2020-2024
- Nippon Chemiphar Co., Ltd. gross profit 2020-2024
- Nippon Chemiphar Co., Ltd. operating profit 2020-2024
- Nippon Chemiphar Co., Ltd. total assets 2020-2024
- Nippon Chemiphar Co., Ltd. net cash 2020-2024
- Nippon Chemiphar Co., Ltd. total equity 2020-2024
- Mochida Pharmaceutical Co., Ltd. liabilities 2020-2024
- Mochida Pharmaceutical Co., Ltd. revenue 2020-2024
- Mochida Pharmaceutical Co., Ltd. net income 2020-2024
- Mochida Pharmaceutical Co., Ltd. gross profit 2020-2024
- Mochida Pharmaceutical Co., Ltd. total assets 2020-2024
- Mochida Pharmaceutical Co., Ltd. net cash 2020-2024
- Mochida Pharmaceutical Co., Ltd. operating profit 2020-2024
- Mochida Pharmaceutical Co., Ltd. total equity 2020-2024
- KYORIN Pharmaceutical Co., Ltd. net income 2020-2024
- KYORIN Pharmaceutical Co., Ltd. liabilities 2020-2024
- KYORIN Pharmaceutical Co., Ltd. operating profit 2020-2024
- KYORIN Pharmaceutical Co., Ltd. gross profit 2020-2024
- KYORIN Pharmaceutical Co., Ltd. net cash 2020-2024
- KYORIN Pharmaceutical Co., Ltd. revenue 2020-2024
- KYORIN Pharmaceutical Co., Ltd. total equity 2020-2024
- Kissei Pharmaceutical Co., Ltd. net income 2020-2024
- KYORIN Pharmaceutical Co., Ltd. total assets 2020-2024
- Kissei Pharmaceutical Co., Ltd. gross profit 2020-2024
- Kissei Pharmaceutical Co., Ltd. liabilities 2020-2024
- Kissei Pharmaceutical Co., Ltd. revenue 2020-2024
- Kissei Pharmaceutical Co., Ltd. total assets 2020-2024
- Kissei Pharmaceutical Co., Ltd. total equity 2020-2024
- Kissei Pharmaceutical Co., Ltd. operating profit 2020-2024
- Kissei Pharmaceutical Co., Ltd. net cash 2020-2024
- Kaken Pharmaceutical Co., Ltd. revenue 2020-2024
- Kaken Pharmaceutical Co., Ltd. liabilities 2020-2024
- Kaken Pharmaceutical Co., Ltd. net income 2020-2024
- Kaken Pharmaceutical Co., Ltd. net cash 2020-2024
- Kaken Pharmaceutical Co., Ltd. operating profit 2020-2024
- Kaken Pharmaceutical Co., Ltd. gross profit 2020-2024
- Kaken Pharmaceutical Co., Ltd. total equity 2020-2024
- Kaken Pharmaceutical Co., Ltd. total assets 2020-2024
- JCR Pharmaceuticals Co., Ltd. net income 2020-2024
- JCR Pharmaceuticals Co., Ltd. liabilities 2020-2024
- JCR Pharmaceuticals Co., Ltd. gross profit 2020-2024
- JCR Pharmaceuticals Co., Ltd. revenue 2020-2024
- JCR Pharmaceuticals Co., Ltd. total assets 2020-2024